Clinical Trial Update: Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 safety study of interleukin-7 in recipients of a hematopoietic stem cell transplant (peripheral blood) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: Cytheris, Inc. | Conditions: AML, CML | Phase 1 | Status: COMPLETED